Search by Drug Name or NDC
NDC 00009-7224-02 Atgam 50 mg/mL Details
Atgam 50 mg/mL
Atgam is a INTRAVENOUS INJECTION, SOLUTION in the PLASMA DERIVATIVE category. It is labeled and distributed by Pharmacia & Upjohn Company LLC. The primary component is EQUINE THYMOCYTE IMMUNE GLOBULIN.
Product Information
| NDC | 00009-7224 |
|---|---|
| Product ID | 0009-7224_9c95f217-8fd9-45d6-bccf-46821cad14fa |
| Associated GPIs | 99402540102220 |
| GCN Sequence Number | 034336 |
| GCN Sequence Number Description | lymphocyte IG,antithymocyt,equ AMPUL 50 MG/ML INTRAVEN |
| HIC3 | Z2E |
| HIC3 Description | IMMUNOSUPPRESSIVES |
| GCN | 43749 |
| HICL Sequence Number | 014404 |
| HICL Sequence Number Description | LYMPHOCYTE IMMUNE GLOBULIN,ANTITHYMOCYTE (EQUINE) |
| Brand/Generic | Brand |
| Proprietary Name | Atgam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | EQUINE THYMOCYTE IMMUNE GLOBULIN |
| Product Type | PLASMA DERIVATIVE |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/mL |
| Substance Name | EQUINE THYMOCYTE IMMUNE GLOBULIN |
| Labeler Name | Pharmacia & Upjohn Company LLC |
| Pharmaceutical Class | Antibody-Surface Protein Interactions [MoA], Immunoglobulin G [EPC], Immunoglobulins [CS], Increased T Lymphocyte Destruction [PE], Lymphocyte Function Alteration [PE] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103676 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00009-7224-02 (00009722402)
| NDC Package Code | 0009-7224-02 |
|---|---|
| Billing NDC | 00009722402 |
| Package | 5 AMPULE in 1 CARTON (0009-7224-02) / 5 mL in 1 AMPULE (0009-7224-01) |
| Marketing Start Date | 1981-11-17 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |